Literature DB >> 1310259

Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently.

M Leid1, P Kastner, R Lyons, H Nakshatri, M Saunders, T Zacharewski, J Y Chen, A Staub, J M Garnier, S Mader.   

Abstract

We have purified and cloned a HeLa cell nuclear protein that strongly stimulates binding of retinoic acid and thyroid hormone receptors (RARs and TRs) to response elements. The purified protein is a human retinoid X receptor beta (hRXR beta). Three murine members of the RXR family (mRXR alpha, beta, and gamma) have also been cloned, and their interactions with RARs and TRs have been investigated. Under conditions where RAR, RXR, and TR bound poorly as homodimers to various response elements, strongly cooperative RAR-RXR and TR-RXR binding was observed. The binding efficiency was dependent on the sequence, relative orientation, and spacing of the repeated motifs of response elements. We show also that unstable RAR-RXR heterodimers were formed in solution, and that C-terminal sequences and the DNA-binding domains of both receptors were required for efficient formation of stable heterodimers on response elements. These findings suggest a convergence of the signaling pathways of some members of the nuclear receptor superfamily.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310259     DOI: 10.1016/0092-8674(92)90478-u

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  280 in total

1.  In vivo transcription factor recruitment during thyroid hormone receptor-mediated activation.

Authors:  M K Kim; J S Lee; J H Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

2.  Structure of the RXR-RAR DNA-binding complex on the retinoic acid response element DR1.

Authors:  F Rastinejad; T Wagner; Q Zhao; S Khorasanizadeh
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

3.  Isolation of a full-length cDNA clone encoding a N-terminally variant form of the human retinoid X receptor beta.

Authors:  K Fleischhauer; J H Park; J P DiSanto; M Marks; K Ozato; S Y Yang
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

4.  The human cDNA sequence homologous to the mouse MHC class I promoter-binding protein gene contains four additional codons in lymphocytes.

Authors:  C Epplen; J T Epplen
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

5.  Screening for ligands of human retinoid X receptor-alpha using ultrafiltration mass spectrometry.

Authors:  Dongting Liu; Jian Guo; Yan Luo; David J Broderick; Michael I Schimerlik; John M Pezzuto; Richard B van Breemen
Journal:  Anal Chem       Date:  2007-11-13       Impact factor: 6.986

6.  Expression and regulation of nuclear retinoic acid receptors in human lymphoid cells.

Authors:  Mark Ballow; Xiaochuan Wang; Shunan Xiang; Cheryl Allen
Journal:  J Clin Immunol       Date:  2003-01       Impact factor: 8.317

7.  Degradation of retinoid X receptor alpha by TPA through proteasome pathway in gastric cancer cells.

Authors:  Xiao-Feng Ye; Su Liu; Qiao Wu; Xiao-Feng Lin; Bing Zhang; Jia-Fa Wu; Ming-Qing Zhang; Wen-Jin Su
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

8.  The chicken retinoid-X-receptor-gamma gene gives rise to two distinct species of mRNA with different patterns of expression.

Authors:  E A Seleiro; D Darling; P M Brickell
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

9.  Physical mapping of the retinoid X receptor B gene in mouse and human.

Authors:  T Nagata; E H Weiss; K Abe; K Kitagawa; A Ando; Y Yara-Kikuti; M F Seldin; K Ozato; H Inoko; M Taketo
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

10.  Two silencing sub-domains of v-erbA synergize with each other, but not with RXR.

Authors:  B Martin; R Renkawitz; M Muller
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.